News | August 28, 2007

ACS Patients Can Move Out of Emergency Department

August 29, 2007 - Patients with suspected acute coronary syndrome (ACS) who are admitted to the hospital from the emergency department have similar outcomes whether they are admitted to cardiology units or family practice units, a finding that might help alleviate emergency department overcrowding by moving ACS patients out of the emergency department more quickly. The study appears online in the Annals of Emergency Medicine (“Do Emergency Department Patients With Possible Acute Coronary Syndrome Have Better Outcomes When Admitted to Cardiology Versus Other Services?”)

“This study should reassure emergency physicians, under pressure to move admitted patients out of the emergency department as quickly as possible, that they have a choice about where to admit possible ACS patients,” said lead study author David A. Katz, M.D. of the VA Iowa City Health Care System in Iowa City. “Given the volume of patients with possible ACS treated in emergency departments – five million every year – and the shortage of cardiology beds at certain times, emergency physicians can safely admit many of these patients to non-cardiology units and possibly reduce overcrowding in their emergency departments.”

Of the 544 patients enrolled in the study, 372 were admitted to cardiology and 172 were admitted to non-cardiology units. Researchers assessed whether patients received recommended therapy in the emergency department and during hospitalization; in addition, patients were assessed in terms of 30-day outcome. Although the cardiology patients received more aggressive testing than the non-cardiology patients, the overall outcomes were very similar. ACS can predict future, more serious problems, such as heart attack. However, certain symptoms that suggest ACS may result from other conditions such as indigestion, anxiety and respiratory problems.

“When patients come to the emergency department with symptoms of possible ACS, emergency physicians must consider a whole constellation of possible diagnoses, and sometimes patients simply need more time to be evaluated as an inpatient,” said Dr. Katz. “Emergency physicians can identify patients who are more likely to benefit from inpatient cardiology care, as well as those with less clear-cut presentations who may be more likely to benefit from generalist care.”

The study recommends larger future studies with longer follow-up on patient outcomes and recommends collaboration between cardiologists and generalists in managing these hospitalized patients based on their underlying risk of future adverse cardiovascular (and non-cardiovascular) events.

For more information: www.acep.org


Related Content

News | Vascular Closure Devices

April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

Home April 16, 2024
Home
News | Vascular Closure Devices

September 16, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced that Dr. Magnus ...

Home September 16, 2022
Home
News | Vascular Closure Devices

November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies ...

Home November 09, 2021
Home
News | Vascular Closure Devices

July 15, 2021 — Vivasure Medical announced its development program for PerQseal Blue, a sutureless and fully ...

Home July 15, 2021
Home
News | Vascular Closure Devices

August 17, 2020 — Veryan Medical announced it will support Vasorum in the commercialization of the Celt atrial closure ...

Home August 17, 2020
Home
Videos | Vascular Closure Devices

Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix, explains the trend ...

Home October 17, 2019
Home
Technology | Vascular Closure Devices

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

Home April 03, 2019
Home
Technology | Vascular Closure Devices

December 20, 2018 — Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food ...

Home December 20, 2018
Home
News | Vascular Closure Devices

November 21, 2018 – Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for ...

Home November 21, 2018
Home
News | Vascular Closure Devices

November 12, 2018 — The Vascade MVP vascular closure system met its endpoints compared to manual compression in a ...

Home November 11, 2018
Home
Subscribe Now